You searched for "operation"
The Bladder & Bowel UK Symposium North West 2025
The Bladder & Bowel UK Symposium provides healthcare professionals with an excellent opportunity to receive relevant education from national speakers. The event includes a brand new programme of inspirational lectures, multi-disciplinary discussions and case studies to influence best practices, together with an extensive exhibition including company representatives and charitable services.Demanding cases or nightmares in uro-oncology? Jan/Feb 2022
When less is more: percutaneous biopsy and tumour seeding in papillary renal cell carcinoma Renal cell carcinoma (RCC) accounted for 2.2% of new cancer diagnoses worldwide in 2018 with over 400,000 new cases and 175,098 deaths [1]. The majority of...Small renal masses – diagnosis and management
Renal cancer is the eighth most common cancer in the UK and accounts for about 3% of all new cancer diagnoses [1]. The incidence rates are steadily rising, with the highest rates being in older men and women. This rise...The how, why and when of bladder washouts: a guide
Bladder washouts are a treatment usually employed by the urology team, more often in an inpatient setting, and commonly indicated for haematuria with clot retention and catheter bypassing [1,2]. Bladder washout is a cornerstone of treatment in urology wards, yet...New ultrasound imaging technique reliably spots prostate cancer, initial patient trial reveals
A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh, Scotland. The ongoing clinical trial demonstrated an initial 94% sensitivity...USANZ Trainee Week 2022 – a trip down under
The BAUS Section of Trainees (BSoT) opened applications for two senior UK urology trainees to be sponsored to attend the annual Urological Society of Australia and New Zealand (USANZ) Trainee Week, in Melbourne. The week is held in November each...
Thulium laser: the new kid ‘en bloc’
Transurethral resection of bladder tumour (TURBT) is considered the gold standard for management of bladder cancer. Residual rates of 15-53% at second TURB and upstaging rates of 4-29% with muscle invasion have been reported. The quality and result of the...Demanding cases or nightmares in endourology? Jan/Feb 2017
In the fifth article in this series the authors describe some of the most complex cases they have encountered. Case 1 A 45-year-old woman was admitted under the care of the medical team with shortness of breath, renal failure and...Onco-fertility: a review
Subfertility or infertility is a major problem affecting men diagnosed with testicular cancer (TC) either due to the disease itself [1], or as a result of management [2]. TC is the most prevalent cancer affecting men of reproductive age [3]....
SUSPEND suspended MET
This review is on the recent groundbreaking evidence on medical expulsive therapy (MET). MET using alpha adrenergic blockers (like tamsulosin) are in regular clinical practice. Even though it is an off label prescription, it is well accepted and practised world...
Defining adjuvant, consolidative, and salvage treatment after RP
The most common oncologic outcome following radical prostatectomy (RP) for localised prostate cancer is achieving undetectable prostate-specific antigen (PSA) levels (<0.1 ng/ml), indicating an absence of detectable disease. However, the landscape of RP is shifting as active surveillance becomes the...
